USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 170 filers reported holding USANA HEALTH SCIENCES INC in Q1 2020. The put-call ratio across all filers is 16.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $438,696 | -45.0% | 7,485 | -40.8% | 0.00% | -33.3% |
Q2 2023 | $797,582 | +7.5% | 12,652 | +7.3% | 0.01% | 0.0% |
Q1 2023 | $741,906 | +116919.9% | 11,795 | -1.1% | 0.01% | +20.0% |
Q4 2022 | $634 | -99.9% | 11,922 | +17.5% | 0.01% | -16.7% |
Q3 2022 | $569,000 | -25.0% | 10,145 | -3.3% | 0.01% | -25.0% |
Q2 2022 | $759,000 | -5.1% | 10,495 | +4.3% | 0.01% | 0.0% |
Q1 2022 | $800,000 | -10.4% | 10,067 | +14.1% | 0.01% | -11.1% |
Q4 2021 | $893,000 | +6.4% | 8,826 | -3.1% | 0.01% | -10.0% |
Q3 2021 | $839,000 | -7.5% | 9,104 | +2.8% | 0.01% | 0.0% |
Q2 2021 | $907,000 | +1.3% | 8,852 | -3.4% | 0.01% | -9.1% |
Q1 2021 | $895,000 | +25.0% | 9,166 | -1.3% | 0.01% | +10.0% |
Q4 2020 | $716,000 | +4.5% | 9,289 | -0.1% | 0.01% | -23.1% |
Q3 2020 | $685,000 | +52.2% | 9,295 | +51.5% | 0.01% | +62.5% |
Q2 2020 | $450,000 | +23.3% | 6,135 | -2.9% | 0.01% | 0.0% |
Q1 2020 | $365,000 | +9.3% | 6,316 | +48.4% | 0.01% | +33.3% |
Q4 2019 | $334,000 | +11.7% | 4,256 | -2.8% | 0.01% | +20.0% |
Q3 2019 | $299,000 | -17.4% | 4,379 | -3.9% | 0.01% | -16.7% |
Q2 2019 | $362,000 | – | 4,556 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |